// App-Quantinova.ai

523 2016 ATVB : Factor XIIa: New Insights on Chemical Tractability and Target Indications From a Potent and Selective Tool Inhibitor

Researchers

Presenter

  • Xinkang Wang

Principal Investigators

  • Xueping Zhou

  • Aimie M Ogawa

  • Kim -Neil

  • Weizhen Wu

  • Gino Castriota

  • Dietmar A Seiffert

  • David Gutstein

  • Zhu Chen

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Human albumin

Drug/Treatment

  • Human serum albumin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved